Are you Dr. Sica?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Page St
# Southcoa
New Bedford, MA 02740Phone+1 508-961-5919Fax+1 508-961-5916
Summary
- Dr. Roberto Sica, MD is an oncologist in New Bedford, Massachusetts. He is currently licensed to practice medicine in Massachusetts, New York, and California. He is affiliated with Montefiore Medical Center.
Education & Training
- Steward Carney HospitalResidency, Internal Medicine, 2007 - 2010
- University of Buenos AiresClass of 1998
Certifications & Licensure
- CA State Medical License 2016 - 2026
- IL State Medical License 2014 - 2026
- MA State Medical License 2010 - 2026
- NY State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 120 citationsAxicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma inclu...Ahmed Abbasi, Stephen Peeke, Nishi Shah, Jennat Mustafa, Fariha Khatun
Journal of Hematology & Oncology. 2020-01-03 - 20 citationsMultiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry DataGurbakhash Kaur, Mateo Mejia Saldarriaga, Nishi Shah, Donna Catamero, Lihua Yue
Clinical Lymphoma, Myeloma & Leukemia. 2021-04-01 - 263 citationsSeroconversion rates following COVID-19 vaccination among patients with cancer.Astha Thakkar, Jesus D. Gonzalez-Lugo, Niyati Goradia, Radhika Gali, Lauren C. Shapiro
Cancer Cell. 2021-08-09
Press Mentions
- Should Therapy for Hematologic Malignancies Be Modified to Mitigate Poor COVID-19 Outcomes?February 25th, 2021